DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/67026f/hiv_pain_pipelin) has announced the addition of Global Markets Direct's new report "HIV Pain - Pipeline Review, H2 2011" to their offering.
Global Markets Direct's, 'HIV Pain - Pipeline Review, H2 2011', provides an overview of the HIV Pain therapeutic pipeline. This report provides information on the therapeutic development for HIV Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for HIV Pain. 'HIV Pain - Pipeline Review, H2 2011' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Scope
- A review of the HIV Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the HIV Pain pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
Key Topics Covered:
- Introduction
- Global Markets Direct Report Coverage
- HIV Pain Overview
- Therapeutics Development
- An Overview of Pipeline Products for HIV Pain
- HIV Pain Therapeutics under Development by Companies
- HIV Pain Therapeutics under Investigation by Universities/Institutes
- Early Clinical Stage Products
- Comparative Analysis
- Pre-Clinical Stage Products
- Comparative Analysis
- HIV Pain Therapeutics - Products under Development by Companies
- HIV Pain Therapeutics - Products under Investigation by Universities/Institutes
- Companies Involved in HIV Pain Therapeutics Development
- TheraQuest Biosciences, LLC
- HIV Pain - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Drug Profiles
- UC-781 - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- TQ-1021 - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
- Expert Panel Validation
For more information visit http://www.researchandmarkets.com/research/67026f/hiv_pain_pipelin